Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease.
Juste RA, Elguezabal N, Garrido JM, Pavon A, Geijo MV, Sevilla I, Cabriada JL, Tejada A, García-Campos F, Casado R, Ochotorena I, Izeta A, Greenstein RJ. Juste RA, et al. Among authors: ochotorena i. PLoS One. 2008 Jul 2;3(7):e2537. doi: 10.1371/journal.pone.0002537. PLoS One. 2008. PMID: 18596984 Free PMC article.
Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls.
Juste RA, Elguezabal N, Pavón A, Garrido JM, Geijo M, Sevilla I, Cabriada JL, Tejada A, García-Campos F, Casado R, Ochotorena I, Izeta A. Juste RA, et al. Among authors: ochotorena i. Int J Infect Dis. 2009 Mar;13(2):247-54. doi: 10.1016/j.ijid.2008.06.034. Epub 2008 Oct 15. Int J Infect Dis. 2009. PMID: 18922720 Free article.
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
Fernández O, Izquierdo G, Fernández V, Leyva L, Reyes V, Guerrero M, León A, Arnaiz C, Navarro G, Páramo MD, Cuesta A, Soria B, Hmadcha A, Pozo D, Fernandez-Montesinos R, Leal M, Ochotorena I, Gálvez P, Geniz MA, Barón FJ, Mata R, Medina C, Caparrós-Escudero C, Cardesa A, Cuende N; Research Group Study EudraCT 2008-004015-35. Fernández O, et al. Among authors: ochotorena i. PLoS One. 2018 May 16;13(5):e0195891. doi: 10.1371/journal.pone.0195891. eCollection 2018. PLoS One. 2018. PMID: 29768414 Free PMC article. Clinical Trial.
Potential applications of nanotechnologies to Parkinson's disease therapy.
Linazasoro G; Nanotechnologies for Neurodegenerative Diseases Study Group of the Basque Country (NANEDIS). Linazasoro G, et al. Parkinsonism Relat Disord. 2008;14(5):383-92. doi: 10.1016/j.parkreldis.2007.11.012. Epub 2008 Mar 7. Parkinsonism Relat Disord. 2008. PMID: 18329315 Review.